Asia
Biocon Biologics in-licenses an early-stage biosimilar asset, will undertake development, manufacturing and commercialization under its own label
Development of the world’s first holotomographic microscope with 3D fluorescence recognised as photonics breakthrough by the 2019 Microscopy Today Innovation Award
Tan Tock Seng Hospital and Lucence are developing a next generation decision support tool for liver cancer patients, which aims to reduce the risks associated with liver cancer surgery.
Companies from across the globe provide updates on their business and pipelines.
Single-use TPE tubing is up to 2.5 times longer lasting over extended production in peristaltic applications
Innovate Biopharmaceuticals, Inc. and RDD Pharma, Ltd announced that the two companies entered into a definitive merger agreement pursuant to which Innovate agreed to acquire all of the outstanding capital stock of privately-held RDD in exchange for a combination of common and preferred shares.
MRI evaluation suggests slowing of cartilage damage and potential chondroprotection in osteoarthritis of the knee
Cerecin continues to strengthen its experienced team in Asia Pacific as it accelerates clinical development plans
BioSpace scanned the WARN (Worker Adjustment and Retraining Notification) notices across the country and compiled a small list of recent layoffs across the industry.
It was another busy week for clinical trials. Here’s a look.
PRESS RELEASES